Miguel Forte | Chief Executive Officer
Zelluna Immunotherapy

Miguel Forte, Chief Executive Officer, Zelluna Immunotherapy

Currently the CEO of Zelluna Immunotherapy and visiting Professor at the Lisbon and Aveiro Universities in Portugal. Currently also serving as Chief Commercialization Officer and Chair of the Commercialization Committee of the International Society of Cell and Gene Therapy (ISCT). From February 2006 to January 2010 was VP of Global Medical Affairs at UCB. In 2004, joined Nabi Pharmaceuticals as the VP of Clinical, Medical and Regulatory Affairs in Europe. After several clinical, academic and regulatory positions in the public sector in Portugal and at the EMA, spent six years with Bristol-Myers Squibb in various positions including Country Medical Director, Executive Director of Infectious Diseases, Immunology and Dermatology and VP of International Medical Organization in Portugal and Belgium. Holds an M.D. from the Faculty of Medicine of the University of Lisbon, Portugal, and a Ph.D. in Immunology from the University of Birmingham, UK, an accreditation as Specialist in Infectious Diseases and a certificate on Health Economics of Pharmaceuticals and Medical Technologies (HEP). He is Fellow of the Faculty of Pharmaceutical Medicine of the RCP in the UK.

Appearances:



Conference Day 1: Thursday 16th May 2019 @ 16:05

Short (10 minute) company presentations followed by panel discussion: Development strategies for CAR-T and TCR therapies with the late stage in mind

  • Allogenic vs autologous
  • Understanding different opportunities: selecting the correct product for the appropriate purpose
  • Improving outcomes tackling solid tumours with CAR-T therapy
  • Moving towards a more off the shelf approach for better cost of goods

Conference Day 1: Thursday 16th May 2019 @ 16:05

Miguel Forte - Company Presentation

Conference Day 1: Thursday 16th May 2019 @ 16:30

Pitch 4. A new TCR approach to take solid tumours

Conference Day 1: Thursday 16th May 2019 @ 17:05

Panel discussion: Development strategies for CAR-T and TCR therapies with the late stage in mind

Conference Day 2: Friday 17th May 2019 @ 11:00

Chair's remarks

last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.